Search

everythinglearnresearchcommunity

for

Search:↓

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

Analog 23 is a promising compound for prostate cancer treatment.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Clascoterone cream could be used for other skin conditions affected by hormones.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

The method can measure multiple steroids in human hair to study long-term steroid metabolism, especially in newborns and children.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Chromosomal differences affect how muscle cells respond to testosterone.

The method accurately measures certain steroids in human hair, showing different levels in males and females.

A new method to make finasteride for hair loss treatment was developed.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Clascoterone may be an effective topical treatment for hair loss.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

MK-386 lowers DHT in blood and skin but not in semen.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Clascoterone is safe for the heart, even at high doses.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.